Oncopeptides’ 25 largest shareholders
Information provided by MFN. Updated quarterly.
| Name | ONCO | ONCO C | Capital | Votes | Verified |
|---|---|---|---|---|---|
| HealthCap VIII L.P. | 45,616,834 | 11.54% | 11.93% | 2026-05-27 | |
| HealthCap VI L.P. | 15,562,345 | 3.94% | 4.07% | 2026-05-27 | |
| Avanza Pension | 21,908,473 | 5.54% | 5.21% | 2026-05-27 | |
| Oncopeptides AB | 14,138,885 | 3.58% | 0.37% | 2026-05-27 | |
| Handelsbanken Funds | 7,883,911 | 1.99% | 2.06% | 2026-05-27 | |
| Nordnet Pension Insurance | 7,840,965 | 1.98% | 2.05% | 2026-05-27 | |
| SEB Funds | 2,834,700 | 0.72% | 0.74% | 2026-04-30 | |
| Swedbank Insurance | 2,540,519 | 0.64% | 0.66% | 2026-05-27 | |
| Jakob Lindberg | 2,348,201 | 0.59% | 0.61% | 2026-05-27 | |
| Molcap Invest AB | 2,120,047 | 0.54% | 0.55% | 2026-03-31 | |
| Handelsbanken Life Insurance AB | 1,953,440 | 0.49% | 0.51% | 2026-05-27 | |
| Per Wold-Olsen | 1,915,935 | 0.48% | 0.50% | 2026-03-17 | |
| Ingrid Hedbom | 1,880,000 | 0.48% | 0.49% | 2026-05-27 | |
| Zetterstedt Holding AB | 1,800,000 | 0.46% | 0.47% | 2026-05-27 | |
| Lennart Stenberg | 1,664,504 | 0.42% | 0.44% | 2026-04-28 | |
| Storebrand Asset Management | 1,651,137 | 0.42% | 0.43% | 2026-03-31 | |
| Ulf Nolén | 1,650,000 | 0.42% | 0.43% | 2026-05-27 | |
| Magnus Karlsson | 1,642,531 | 0.42% | 0.43% | 2026-05-27 | |
| Försäkringsaktiebolaget Skandia | 1,429,584 | 0.36% | 0.37% | 2026-05-27 | |
| Hasan Taspinar | 1,272,000 | 0.32% | 0.33% | 2026-05-27 | Nordea Life & Pension | 1,236,890 | 0.32% | 0.33% | 2026-04-28 |
| Kjell Hasslert | 1,187,554 | 0.30% | 0.31% | 2026-04-28 | |
| Johan Zetterstedt | 1,105,527 | 0.28% | 0.29% | 2026-04-28 | |
| Timmy Jansson | 1,102,849 | 0.28% | 0.29% | 2026-05-27 | |
| Douglas Storckenfeldt | 1,100,000 | 0.28% | 0.29% | 2026-04-28 | |
| PLUS Asset Management | 1,053,240 | 0.27% | 0.28% | 2026-05-31 | |
| Total 25 | 129,072,097 | 14,138,885 | 36.21% | 34.09% | |
| Others | 252,076,021 | 0 | 63.79% | 65.91% | |
| Total | 381,148,118 | 14,138,885 | 100.00% | 100.00% |